Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $69.31M.
ENTERPRISE VALUE (EV)
$69.31M
LENSAR Inc
Market Cap
$82.29M
Enterprise Value (EV)
$69.31M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| LENSAR Inc (LNSR) | $82.29M | $69.31M |
| Citius Oncology, Inc. (CTOR)vs › | $82.26M | $75.91M |
| Nutriband Inc. (NTRB)vs › | $81.69M | $78.46M |
| MediciNova, Inc. (MNOV)vs › | $82.94M | $57.64M |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | $43.73M |
| Pulmonx Corporation (LUNG)vs › | $80.04M | $80.41M |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.61M | $31.18M |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | $55.93M |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.01M | $51.50M |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.17M | $76.43M |
Market Cap
$82.29M
Total Debt
$0.00
Cash
$12.97M
Enterprise Value
$69.31M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
